as 12-20-2024 4:00pm EST
Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery. DehydraTECH can increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, reduce the time of onset from 1-2 hours to minutes, and mask unwanted tastes. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood-brain barrier. The company has four reportable segments: Intellectual Property Licensing which generates maximum revenue, B2B Production, Research and Development, and Corporate. Geographically, it derives revenue from the United States and Canada.
Founded: | 2004 | Country: | Canada |
Employees: | N/A | City: | KELOWNA |
Market Cap: | 38.9M | IPO Year: | N/A |
Target Price: | $11.00 | AVG Volume (30 days): | 202.7K |
Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -0.47 | EPS Growth: | N/A |
52 Week Low/High: | $1.20 - $6.85 | Next Earning Date: | 01-10-2025 |
Revenue: | $464,278 | Revenue Growth: | 105.24% |
Revenue Growth (this year): | 20.39% | Revenue Growth (next year): | 113.25% |
LEXX Breaking Stock News: Dive into LEXX Ticker-Specific Updates for Smart Investing
ACCESSWIRE
3 days ago
ACCESSWIRE
4 days ago
ACCESSWIRE
5 days ago
TipRanks
12 days ago
ACCESSWIRE
13 days ago
Zacks Small Cap Research
17 days ago
Newsfile
22 days ago
Simply Wall St.
24 days ago
The information presented on this page, "LEXX Lexaria Bioscience Corp. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.